Canine Upper Respiratory Infection: Diagnostic and Therapeutic Approach

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Canine upper respiratory infections (URIs) are primarily caused by viral agents like canine adenovirus type 2 and canine parainfluenza virus, often complicated by secondary bacterial colonization, notably Bordetella bronchiseptica. Transmission occurs via aerosol, fomites, and direct contact, with high-density housing amplifying spread.
• Diagnostic thresholds for further investigation include signs persisting beyond 7-10 days, worsening clinical signs, purulent nasal discharge, fever, or systemic illness, especially in puppies, brachycephalic breeds, or immunocompromised individuals.
• First-line diagnostics typically involve PCR panels on oropharyngeal and nasal swabs for rapid pathogen identification, complemented by cytology for inflammatory cell assessment and bacterial culture with susceptibility testing for targeted antimicrobial therapy.
• Antimicrobial therapy is indicated for suspected or confirmed bacterial infections, characterized by purulent discharge, systemic signs, or progression despite supportive care, with culture-guided selection being paramount due to variable susceptibility patterns.
• Supportive care, including humidification, nutritional support, and fluid therapy, is the cornerstone of management for uncomplicated viral URIs, while antitussives are generally not recommended due to potential interference with airway clearance.
• Outbreak control in group housing necessitates strict isolation of affected individuals, cohort separation, review of vaccination status, and thorough environmental disinfection to mitigate rapid transmission.

This article provides a structured approach to upper respiratory infection (URI) in dogs for the practicing veterinarian. It covers the major infectious etiologies, the diagnostic reasoning pathway from presentation to laboratory confirmation, and the therapeutic decision framework including antimicrobial stewardship, supportive care, and management of outbreak situations in group housing. The focus is confined to the upper airways, nasal passages, pharynx, larynx, and trachea, lower respiratory tract disease is addressed elsewhere.

The clinical question this article answers is practical: when a dog presents with acute onset nasal discharge, sneezing, and cough, how does the clinician distinguish self-limiting viral infection from bacterial disease requiring targeted therapy, and what diagnostic and therapeutic steps are justified in each scenario? The approach emphasizes pattern recognition, risk stratification based on signalment and environment, and judicious use of diagnostics before antimicrobial commitment.

At a Glance

Pathophysiology of Canine Upper Respiratory Infection

The upper respiratory tract of the dog is defended by mucociliary clearance, secretory immunoglobulin A, and resident commensal flora. Infectious agents disrupt these barriers through several mechanisms. Viral pathogens such as canine adenovirus type 2 and canine parainfluenza virus damage the ciliated epithelium directly, reducing mucociliary clearance and exposing basement membranes. This creates a permissive environment for secondary bacterial colonization, most commonly by Bordetella bronchiseptica, which adheres to ciliated cells and inhibits their function through secreted toxins.

The clinical syndrome known as kennel cough or canine infectious respiratory disease complex reflects this sequential pathophysiology. The initial viral insult produces a dry, paroxysmal cough and serous nasal discharge. Bacterial superinfection then converts the discharge to mucopurulent and prolongs the clinical course. In shelter environments, the transmissibility of this complex is well documented, and affected dogs frequently face reduced adoption rates and, in severe cases, euthanasia when outbreaks overwhelm limited resources. This observation underscores the importance of rapid identification and containment in group housing.

Etiologic Agents and Their Clinical Signatures

Viral Pathogens

Canine adenovirus type 2 and canine parainfluenza virus are the most commonly implicated viral agents in canine URI. Both produce similar clinical pictures: acute onset cough, pharyngitis, and mild fever that typically resolves within 7 to 10 days in otherwise healthy adults. Canine respiratory coronavirus contributes to the complex, often as a coinfection that increases disease severity. The clinical overlap between these agents means that etiologic diagnosis requires laboratory confirmation instead of syndromic recognition alone.

Bacterial Pathogens

Bordetella bronchiseptica is the primary bacterial pathogen in canine URI. It is a gram-negative coccobacillus with tropism for ciliated respiratory epithelium. Infection produces a characteriztic honking cough that can persist for weeks. Importantly, B. bronchiseptica is zoonotic in limited contexts, particularly for immunocompromised humans, and this should inform client communication in households with vulnerable individuals.

Streptococcus equi subsp. zooepidemicus is an emerging cause of severe, sometimes fatal, hemorrhagic pneumonia in dogs, although its primary manifestation is lower respiratory. In the upper respiratory tract, it can present as acute pharyngitis and cervical lymphadenopathy. Mycoplasma species, particularly M. cynos, contribute to the complex and are frequently identified as coinfections.

The relative contribution of each agent varies by population and region. In shelter settings, coinfection is the rule instead of the exception, and the presence of multiple pathogens complicates both diagnosis and therapeutic response. This mirrors observations in feline medicine, where coinfection with multiple URI pathogens is common and correlates with more severe histopathologic lesions.

Host Factors and Susceptibility

Age is the strongest predictor of disease severity. Puppies with immature immune systems and incomplete vaccination series develop more severe clinical signs and are at higher risk for progression to pneumonia. Brachycephalic breeds present a unique challenge: their conformational upper airway abnormalities, including stenotic nares and elongated soft palates, impair normal clearance mechanisms and predispose them to chronic or recurrent URI. These patients may require more aggressive diagnostic evaluation and longer therapeutic courses.

Immunocompromised dogs, whether from endogenous disease, chemotherapy, or chronic glucocorticoid use, are at risk for disseminated bacterial infection and atypical presentations. In these patients, early diagnostic sampling and a lower threshold for antimicrobial therapy are appropriate.

Diagnostic Reasoning Framework

The diagnostic approach to canine URI follows a stepwise progression from clinical assessment to targeted laboratory testing. The decision to pursue diagnostics should be guided by duration, severity, and progression of signs.

Clinical Assessment and Triage

The initial evaluation should characterize the cough, nasal discharge, and presence of systemic signs. A dry, honking cough with serous discharge and normal appetite in a vaccinated adult dog suggests viral URI or uncomplicated B. bronchiseptica infection. In this scenario, a 7 to 10 day observation period with supportive care is reasonable before laboratory investigation.

Diagnostics are indicated when any of the following criteria are met: signs persist beyond 10 days, discharge becomes purulent, fever develops, appetite declines, or the dog is a puppy, brachycephalic, or immunocompromised. The presence of systemic signs should prompt thoracic radiographs to exclude lower respiratory involvement, even though this article does not cover that disease in depth.

Laboratory Confirmation

When diagnostic testing is pursued, a combined oropharyngeal and nasal swab submitted for quantitative PCR panel is the most efficient approach. Panels typically include canine adenovirus type 2, canine parainfluenza virus, canine respiratory coronavirus, B. bronchiseptica, and Mycoplasma cynos. The value of PCR lies in its sensitivity and speed, but interpretation requires caution: detection of a pathogen does not prove causation, particularly for organizms like B. bronchiseptica that can be shed by clinically normal carriers.

Cytology of nasal discharge can differentiate suppurative from eosinophilic or lymphocytic inflammation and may reveal intracellular bacteria. Bacterial culture with susceptibility testing is reserved for cases with purulent discharge, suspected antimicrobial resistance, or failure of empirical therapy. Culture is essential when S. equi subsp. zooepidemicus is suspected, as this organizm requires specific media and has public health implications.

Imaging

Skull radiographs or advanced imaging are not indicated in routine URI. They are reserved for chronic or recurrent cases where foreign body, neoplasia, or dental disease is suspected. Thoracic radiographs are indicated when lower respiratory involvement is suspected based on auscultatory findings, tachypnea, or systemic signs.

Treatment Planning and Medical Management

Treatment of canine upper respiratory infection begins with a decision about setting. Most dogs with uncomplicated viral tracheobronchitis can be managed as outpatients with isolation at home. Hospitalization is indicated for dogs with suspected pneumonia, marked lethargy, anorexia lasting more than 48 hours, or respiratory distress. Shelter environments require separate consideration because transmission risk is high and affected dogs may be euthanased when adoption rates fall, as documented in shelter-based studies of kennel cough outbreaks Foley et al., institutional publication on molecular epidemiology of feline bordetellosis. In a shelter, even mildly affected dogs may need isolation wards with dedicated staff and separate airspace.

Antimicrobial therapy is not indicated for every dog with an upper respiratory infection. Most viral infections resolve with supportive care alone. Antibiotics are reserved for dogs with confirmed or strongly suspected bacterial infection, including mucopurulent nasal discharge lasting more than 10 days, fever exceeding 39.7°C, or cytological evidence of septic inflammation. When bacterial infection is suspected, current formulary references should be consulted for dose and duration, and culture and susceptibility testing should guide agent selection where possible. Bordetella bronchiseptica isolates from shelter outbreaks have shown variable susceptibility patterns, which supports the use of culture-guided therapy instead of empirical selection Foley et al., institutional publication on molecular epidemiology of feline bordetellosis.

Antitussive therapy is rarely beneficial. Cough in canine upper respiratory infection serves a clearance function, and suppression may prolong recovery. The human literature on codeine for cough associated with upper respiratory infection shows little evidence of efficacy, and this finding should temper expectations for opioid-based antitussives in dogs Eccles, institutional publication on codeine, cough and upper respiratory infection. When cough is nonproductive and interferes with rest, a trial of a non-opioid antitussive may be considered, but the clinician should reassess response within 48 hours and discontinue if no benefit is seen.

Supportive care forms the backbone of treatment. Humidification via a warm mist vaporiser or steam from a shower can reduce nasal discharge viscosity. Saline nasal drops may be used in brachycephalic breeds where nasal congestion compromises breathing. Appetite stimulation with warmed, strongly aromatic food is often sufficient for mildly affected dogs. Dogs that refuse food for more than 48 hours or that have significant nasal discharge should receive fluid therapy and nutritional support. The MSD Veterinary Manual provides general guidance on supportive care for canine respiratory disease MSD Veterinary Manual professional edition.

Monitoring and Reassessment

Recheck intervals depend on disease severity. Dogs managed as outpatients should be reassessed at 48 to 72 hours. Improvement is expected by day 5 to 7 in uncomplicated viral infection. Dogs that worsen during this period require re-evaluation for bacterial superinfection, aspiration pneumonia, or a noninfectious differential such as a foreign body or neoplasia.

Monitoring parameters include respiratory rate and effort, nasal discharge character and volume, appetite, and activity level. A dog that develops increased respiratory effort, crackles on thoracic auscultation, or productive cough with systemic signs should have thoracic radiographs performed to exclude lower airway involvement. Persistent unilateral nasal discharge, facial deformity, or epistaxis shifts the differential toward foreign body, dental disease, or neoplasia and warrants imaging and rhinoscopy.

The following table summarizes monitoring parameters and the clinical significance of changes:

Differential Prioritization and Diagnostic Decision Points

The differential diagnosis for canine upper respiratory infection includes infectious tracheobronchitis, canine influenza, primary bacterial rhinitis, foreign body, dental disease with oronasal fistula, nasal neoplasia, and fungal rhinitis. The diagnostic pathway is guided by signalment, duration, and lateralisation.

Acute onset with exposure history in a young dog supports infectious tracheobronchitis. Acute onset with high fever and rapid spread through a household or kennel raises suspicion for canine influenza. Chronic signs lasting more than 2 weeks, unilateral discharge, or facial deformity shift the priority toward structural disease. Older dogs with progressive unilateral signs and epistaxis should be evaluated for nasal neoplasia. Fungal rhinitis typically presents with chronic mucopurulent discharge, depigmentation of the nasal planum, and pain on palpation.

The decision to pursue advanced diagnostics depends on response to initial therapy. A dog that improves with supportive care within 5 to 7 days does not require further workup. A dog that fails to improve, worsens, or has atypical features should proceed to imaging, culture, and rhinoscopy. The ACVIM consensus statements provide structured guidance on diagnostic and therapeutic decision-making for respiratory conditions in companion animals ACVIM consensus statements.

Treatment Algorithm

The following algorithm structures the clinical approach:

1. Triage: assess respiratory effort, hydration, and systemic signs. Hospitalize if respiratory distress, suspected pneumonia, or marked lethargy.
2. Differentiate upper from lower respiratory disease using thoracic auscultation and radiographs when doubt exists.
3. For mild, acute disease with exposure history: supportive care, isolation, reassess in 48 to 72 hours.
4. For moderate disease with mucopurulent discharge or fever: add antimicrobial therapy after collecting samples for culture where feasible.
5. For chronic or atypical disease: perform imaging, culture, and rhinoscopy before committing to long-term therapy.
6. Reassess at each visit. Escalate diagnostics if the dog fails to improve within the expected window.

Prognosis and Return to Normal Activity

Most dogs with uncomplicated viral upper respiratory infection recover within 7 to 14 days. Cough may persist for up to 3 weeks in some dogs, particularly those with Bordetella bronchiseptica infection. Dogs should be kept isolated from other dogs for at least 7 days after clinical signs resolve, and ideally for 14 days, because viral shedding can continue after clinical recovery.

Return to normal activity should be gradual. Strenuous exercise may trigger coughing paroxysms and should be avoided until the cough has resolved. Dogs returning to boarding, daycare, or group training environments should be free of clinical signs for at least 7 days to reduce transmission risk.

Persistent cough beyond 3 weeks, recurrence of fever, or development of exercise intolerance warrants re-evaluation for complications including bronchopneumonia, chronic bronchitis, or tracheal collapse. In these cases, thoracic radiographs and airway sampling are indicated instead of repeated empirical antimicrobial courses.

Recognized Complications and Failure Modes

The most consequential failure in managing canine upper respiratory infection is progression to lower airway disease or pneumonia. This transition is often silent in the early phase. Cough that becomes productive, increased respiratory effort, auscultable crackles or wheezes, and deteriorating pulse oximetry readings all signal extension beyond the upper tract. Anorexia lasting more than 48 hours, persistent fever beyond the first three days, or lethargy out of proportion to the physical findings should prompt thoracic radiographs even when the cough sounds "typical" of kennel cough.

A second failure mode is the development of chronic rhinitis or sinusitis after an apparently resolved acute infection. Persistent unilateral nasal discharge, facial deformity, or discharge that becomes purulent after day 10 raises concern for foreign body, dental disease, or fungal infection instead of a simple viral URI. These cases require imaging and often rhinoscopy instead of repeated antibiotic courses.

Treatment failure with antimicrobials warrants specific scrutiny. Bordetella bronchiseptica is intrinsically resistant to some beta-lactams, and susceptibility patterns in shelter populations vary. When a dog fails to improve within 72 hours of appropriate empirical therapy, culture and susceptibility testing from a deep oropharyngeal or transtracheal sample should replace continued blind antibiotic rotation. The shelter setting carries additional risk: molecular epidemiology of feline bordetellosis in two animal shelters demonstrated that B. bronchiseptica can be cultured from a substantial proportion of clinically normal cats, and that infected cats may represent a reservoir for dogs in the same facility. A dog that relapses after returning to a shelter environment may be re-exposed instead of treatment-resistant.

Common Errors in Diagnostic Reasoning

The most frequent error is treating every cough as infectious. Dogs with collapsing trachea, bronchial disease, cardiac cough, or inhaled foreign material present with cough that owners and clinicians attribute to "kennel cough" because the sign is common. The diagnostic framework should include a careful laryngeal and tracheal palpation, assessment of cough character, and a minimum of thoracic auscultation before antimicrobials are dispensed. A cough that is honking, worse with excitement or leash pressure, and absent at rest points to tracheal collapse instead of infection.

A second error is over-reliance on point-of-care PCR panels without clinical correlation. A positive result for a respiratory pathogen confirms exposure or carriage, not causation. The feline literature illustrates this problem: histologic and molecular correlation in shelter cats with acute upper respiratory infection found that many cats positive for multiple pathogens by PCR had lesions attributable to only one agent, and some PCR-positive cats had no corresponding histologic lesion. The same caution applies to dogs. A positive Bordetella PCR in a dog with allergic bronchitis does not prove the cough is bacterial.

A third error is under-treating the patient while over-treating the pathogen. Humidification, rest, nutritional support, and nursing care carry most of the therapeutic weight in viral infections. Antibiotics do not shorten viral shedding or reduce the duration of clinical signs in uncomplicated viral URI. Conversely, withholding antimicrobials in a dog with confirmed bacterial pneumonia or in a puppy with suspected sepsis is equally harmful. The decision should rest on clinical severity, not on the presence of a cough.

Limitations of the Evidence Base

The evidence for canine upper respiratory infection is thinner than most clinicians assume. Much of the therapeutic literature is extrapolated from feline studies, human cough research, or shelter-based observational work. The antitussive evidence is particularly weak. Codeine, cough and upper respiratory infection reviewed the human data and found little support for codeine in cough associated with upper respiratory infection, despite its status as a reference antitussive. Whether this extends to dogs is unknown, but it should temper expectations when antitussives are prescribed.

Expert opinion still differs on several points. The value of routine antimicrobial therapy in shelter dogs with uncomplicated kennel cough remains contested. Some authorities recommend treatment to reduce shedding and improve adoption outcomes, while others argue that antimicrobial use drives resistance without measurable benefit. Vaccination strategies also generate disagreement, particularly regarding the duration of immunity from intranasal products and the need for booster intervals. The ACVIM consensus statements provide structured guidance where evidence permits, but several respiratory questions lack consensus coverage.

Escalation and Referral Criteria

Referral or specialist consultation is warranted when the diagnosis remains uncertain after imaging and laboratory testing, when the dog fails to respond to two appropriate treatment trials, or when chronic rhinitis, suspected neoplasia, or fungal disease enters the differential. A veterinary internal medicine specialist should also be involved when bronchoscopy, rhinoscopy, or advanced imaging such as CT is required. Diagnostic laboratories should be consulted before sampling when unusual pathogens are suspected, since sample type, transport medium, and assay selection materially affect yield.

Regulatory reporting obligations vary by region and by pathogen. Canine influenza is reportable in some jurisdictions, and any cluster of severe respiratory disease in a kennel or shelter should prompt contact with the relevant animal health authority. The WOAH terrestrial animal health standards describe notification expectations for listed diseases, and the AVMA practice resources offer guidance on biosecurity and outbreak response. When in doubt about reporting requirements, a telephone call to the state or provincial veterinarian is the appropriate first step.

Frequently Asked Questions

How Should I Manage Suspected Upper Respiratory Infection When PCR Testing Is Not Available or Affordable?

When molecular testing is unavailable, base the initial diagnosis on signalment, history, and physical examination. A young, recently boarded or adopted dog with acute onset paroxysmal cough, retropharyngeal lymphadenopathy, and a clear nasal discharge most likely has viral tracheobronchitis. Perform a complete blood count and in-house chemistry panel to screen for systemic inflammation. Thoracic radiographs are indicated when fever, lethargy, or abnormal lung sounds suggest lower airway involvement. If clinical signs worsen or fail to improve within 10 days despite supportive care, pursue bacterial culture from a transtracheal wash or bronchoalveolar lavage. Empirical antimicrobial therapy is reserved for dogs with suspected bacterial rhinitis, mucopurulent discharge, or evidence of bronchopneumonia. The MSD Veterinary Manual provides guidance on syndromic diagnosis and empirical treatment selection when confirmatory testing is limited.

What Infection Control Measures Should I Recommend for a Multi-Dog Household or Kennel?

Advise owners that dogs with suspected upper respiratory infection shed infectious organizms for up to two weeks after clinical signs resolve. Separate affected dogs from unaffected dogs for a minimum of 14 days. Use dedicated food bowls, leashes, and bedding for each dog. Clean and disinfect all surfaces with accelerated hydrogen peroxide or bleach diluted 1:32, as many respiratory pathogens are enveloped viruses susceptible to routine disinfectants. Improve ventilation in shared spaces and reduce stocking density. In shelter environments, kennel cough is readily transmissible and reduces adoption rates, so isolation protocols directly affect population outcomes Foley et al., institutional publication on molecular epidemiology of feline bordetellosis. Vaccination against Bordetella bronchiseptica, canine parainfluenza virus, and canine adenovirus type 2 should be current for all dogs entering a group setting, though vaccination does not eliminate shedding.

When Should I Suspect a Primary Bacterial Infection instead of a Viral Process?

Suspect primary bacterial infection when nasal discharge is mucopurulent or hemorrhagic from onset, when there is facial asymmetry or pain on palpation of the nasal cavity, or when fever persists beyond 72 hours. Bordetella bronchiseptica can act as a primary pathogen, particularly in young puppies or immunocompromised adults. Fungal rhinitis from Aspergillus species typically presents with chronic unilateral mucopurulent discharge, sneezing, and depigmentation or ulceration of the nasal planum. A dog that fails to respond to supportive care within 7 to 10 days warrants nasal imaging and sampling. Cytology of nasal discharge showing intracellular bacteria supports bacterial rhinitis. Culture of a deep nasal swab or tissue biopsy is preferred over superficial swabs, which frequently grow commensal organizms. The ACVIM consensus statements address diagnostic thresholds for infectious respiratory disease in dogs.

How Do I Distinguish Upper Respiratory Infection From Early Lower Respiratory Tract Disease?

The key distinction is whether cough originates from the trachea or the bronchi and alveoli. Upper respiratory infection typically produces a dry, honking, paroxysmal cough with a normal respiratory rate and effort. Lower respiratory disease presents with a soft, productive cough, increased respiratory rate, increased inspiratory effort, or abnormal lung sounds on auscultation. Perform thoracic radiographs in any dog with tachypnea, fever, lethargy, or auscultable crackles or wheezes. Pulse oximetry below 95 percent on room air indicates impaired gas exchange and mandates thoracic imaging. Dogs with suspected bacterial bronchopneumonia require antimicrobial therapy, whereas uncomplicated viral tracheobronchitis is managed supportively. Serial recheck examinations at 48 to 72 hour intervals allow early detection of progression. The MSD Veterinary Manual outlines criteria for differentiating upper and lower respiratory syndromes in dogs.

What Should I Document in the Medical Record for a Dog With Suspected Upper Respiratory Infection?

Record the duration and character of cough, nasal discharge, sneezing, and ocular signs. Document vaccination history, particularly for Bordetella, parainfluenza, and adenovirus. Note recent exposure to other dogs through boarding, grooming, dog parks, or shows. Record temperature, respiratory rate, lung auscultation findings, and hydration status at each visit. Document the rationale for any antimicrobial prescription, including the suspected bacterial pathogen and the expected duration of therapy. If PCR or culture is performed, record the sample type, collection site, and laboratory results. Include owner communication about contagiousness, expected duration of clinical signs, and return precautions. Clear documentation supports antimicrobial stewardship and provides a baseline if the dog develops recurrent or chronic respiratory signs.

How Should I Counsel an Owner Whose Dog Has Recurrent Upper Respiratory Infections?

Recurrent episodes, defined as more than two episodes within 12 months, warrant investigation for an underlying structural or immunologic problem. Ask whether clinical signs fully resolve between episodes. Persistent nasal discharge between acute episodes suggests chronic rhinitis, nasal foreign body, or neoplasia. Perform a thorough oral examination to identify oronasal fistulas from dental disease. Consider skull radiographs or computed tomography to evaluate the nasal cavity and frontal sinuses. In young dogs, congenital ciliary dyskinesia or immunodeficiency syndromes are rare but possible. In brachycephalic breeds, stenotic nares and elongated soft palate predispose to secondary bacterial rhinitis. Refer for rhinoscopy and biopsy when imaging identifies a mass or when clinical signs persist beyond four weeks despite appropriate medical therapy. The WOAH terrestrial animal health standards provide context on surveillance for infectious respiratory agents that may have regional importance.

Related Clinical & Scientific Guides

• Feline Hepatic Lipidosis: Nutritional and Medical Management
• Canine Respiratory Infection: Diagnostic Approach and Treatment
• Canine Respiratory Virus: Diagnostic and Management Considerations

References and Further Reading

• Molecular epidemiology of feline bordetellosis in two animal shelters in California, USA.. 2002.
• Attention deficit hyperactivity disorder may be a highly inflammation and immune-associated disease (Review).. 2017.
• Mucopolysaccharidosis type I.. 2014.
• Histologic and molecular correlation in shelter cats with acute upper respiratory infection.. 2011.
• Codeine, cough and upper respiratory infection.. 1996.
• An isolated epizootic of hemorrhagic-like fever in cats caused by a novel and highly virulent strain of feline calicivirus.. 2000.
• ACVIM Consensus Statements. Journal of Veterinary Internal Medicine.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.

Related Articles

• Canine Respiratory Infection: Diagnostic Approach and Treatment
• Canine Respiratory Disease Complex: Diagnostic and Therapeutic Approach
• Canine Gallbladder Disease: Diagnostic and Therapeutic Approach
• Canine Immune-Mediated Myositis: Diagnostic and Therapeutic Approach
• Canine Inflammatory Bowel Disease: Diagnostic and Therapeutic Approach

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.